| 5.19 Data as of May 22 | -0.07 / -1.33%Today’s Change | 4.20 Today|||52-Week Range 8.53 | -24.34% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.50, with a high estimate of 9.50 and a low estimate of 9.50. The median estimate represents a +83.04% increase from the last price of 5.19.

There are no recommendations available.

Move your mouse over a quarter or year to see how estimates have changed over time.




